The Joan and Sanford I. Weill Center for Metabolic Health works towards its goal of better understanding the basic biology and genetics of diabetes, obesity and metabolic disease, and then translating new discoveries into therapeutic approaches. Center investigators use stem cells, cellular and molecular biology, genetics, proteomics, biorepositories and nutritional research to learn about the molecular underpinnings of these diseases, while encouraging behavioral changes to enhance health.
The Weill Center for Metabolic Health aims to become an internationally recognized hub for scientific discovery in metabolism, delivering clinical, translational and molecular breakthroughs in the pathogenesis and treatment of metabolic disease
-
Dr. Laura Alonso is Chief of the Division of Endocrinology, Diabetes and Metabolism and Director of the Weill Center for Metabolic Health. She is an elected member of the American Society for Clinical Investigation, a leading physician-scientist in the field of endocrinology, and an authority on the basic biology of pancreatic beta cell regeneration.
